(1H-Pyrrolo[3,2-c]pyridin-2-yl)methanamine dihydrochloride is primarily utilized in pharmaceutical research and development, particularly in the field of medicinal chemistry. It serves as a key intermediate or building block in the synthesis of biologically active compounds. Its structure is often explored for designing molecules that target specific receptors or enzymes, making it valuable in drug discovery efforts. Researchers investigate its potential in developing treatments for neurological disorders, psychiatric conditions, or other diseases where modulation of specific pathways is required. Additionally, it may be used in preclinical studies to evaluate pharmacokinetics, pharmacodynamics, and toxicity profiles of novel therapeutic agents.